SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 3, 2008
BioMedical Technology Solutions Holdings, Inc.
(Exact name of registrant as specified in its charter)
| | |
Colorado | ____000-52652___ | 26-3161860 |
(State or other jurisdiction of incorporation or organization) | (Commission file number) | (IRS Employer Identification No.) |
9800 Mt Pyramid Court # 350
Englewood, CO 80112
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 653-0100
______________________________________________________
(Former name or former address, if changed since last report)
| |
___ | Written communications pursuant to Rule 425 under the Securities Act |
___ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
ITEM 3.03
MATERIAL MODIFICATION OF RIGHTS OF SECURITY HOLDERS
ITEM 8.01
OTHER EVENTS
Effective with the open of trading on Wednesday, September 3, 2008, the Company’s name change from CET Services, Inc. to BioMedical Technology Solutions Holdings, Inc. will be effective on the OTC Electronic Bulletin Board. Also, effective with the open of trading on September 3, 2008, a one-for-three (1-for-3) reverse split (the “Reverse Split”) of the Company’s outstanding securities was effective. Giving effect to the issuance of approximately 78,033,189 additional shares of common stock in connection with the reverse triangular merger between CET Services and BMTS that was consummated on August 21, 2008, and giving further effect to the Reverse Split, the Company will have approximately 27,880,000 shares issued and outstanding (before giving effect to the impact of rounding up in the Reverse Split).
Effective with the open of trading on Wednesday, September 3, 2008, giving effect to the name change and Reverse Split, the Company’s shares of common stock will begin trading on the Over-The-Counter Bulletin Board under the new ticker symbol “BMTL”.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| | | BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS, INC.
|
Date: September 2, 2008 | By: _/s/ Donald G. Cox ______________ Donald G. Cox, President |
| | |
2
